Quantcast

Latest George Yancopoulos Stories

2014-10-16 08:31:43

Appoints Scientific Advisory Board and VP, Translational Genetics TARRYTOWN, N.Y., Oct. 16, 2014 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that the Regeneron Genetics Center LLC (RGC), a wholly-owned subsidiary, has formed important new collaborations with leading academic institutions and has welcomed prominent experts into new leadership and advisory roles. To date, the RGC has sequenced de-identified samples from over 10,000 individuals, leveraging...

2014-06-02 16:27:58

10 Promising Early-Career Biomedical Researchers Recognized TARRYTOWN, N.Y., June 2, 2014 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced the second annual winners of the Regeneron Prize for Creative Innovation, an award designed to acknowledge, reward, and foster talented early-career biomedical scientists. This year, Regeneron awarded $160,000 in prize money to 10 awardees and two institutions. "The Regeneron Prize for Creative Innovation identifies and...

2014-05-05 08:28:53

TARRYTOWN, N.Y. and MENLO PARK, Calif., May 5, 2014 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Avalanche Biotechnologies, Inc., today announced the formation of a broad collaboration to discover, develop and commercialize novel gene therapy products for the treatment of ophthalmologic diseases. The collaboration covers novel gene therapy vectors and proprietary molecules, discovered jointly by Avalanche and Regeneron, and developed using the Avalanche Ocular...

2014-04-03 16:24:08

Fellowship Program in Collaboration with NASA, Teachers College, Columbia University and STEM Education Leadership Center TARRYTOWN, N.Y., April 3, 2014 /PRNewswire/ -- In a new initiative to promote STEM (Science Technology Engineering Math) education in New York's Hudson Valley, Regeneron Pharmaceuticals, Inc. (Nasdaq: REGN) today announced a collaboration with NASA, Teachers College, Columbia University and the STEM Education Leadership Center of Rye, New York to create the Hudson...

2014-01-13 08:27:55

TARRYTOWN, N.Y., Jan. 13, 2014 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that it has launched a new human genetics initiative via a new wholly owned subsidiary, the Regeneron Genetics Center LLC (RGC). The objective of the RGC is to expand the use of human genetics for defining disease targets and improving the drug development process. The RGC will pursue both large population-based efforts as well as family-based approaches. Central to the...

2014-01-13 08:27:48

This initiative combines world-class clinical care and premier scientific research with the aim of improving patient care and accelerating innovation in drug discovery and development TARRYTOWN, N.Y., Jan. 13, 2014 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Geisinger Health System (Geisinger), one of the largest integrated health systems in the United States serving approximately 3 million residents, today announced a major research collaboration focused on...


Word of the Day
conjunto
  • A style of popular dance music originating along the border between Texas and Mexico, characterized by the use of accordion, drums, and 12-string bass guitar and traditionally based on polka, waltz, and bolero rhythms.
The word 'conjunto' comes through Spanish, from Latin coniūnctus, past participle of coniungere, to join together; see conjoin